[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1025 Introduced in House (IH)]
<DOC>
118th CONGRESS
1st Session
H. R. 1025
To prohibit Federal funding to the Wuhan Institute of Virology and to
require a GAO study regarding Federal funds previously provided to such
institute or to entities affiliated with the Chinese Government.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
February 14, 2023
Mr. Perry (for himself, Mr. Tiffany, Mr. Ogles, Mr. Norman, Mr. Good of
Virginia, Mr. Duncan, Mr. Reschenthaler, Mr. Posey, Ms. Salazar, Mr.
Jackson of Texas, Mr. Lamborn, and Mr. Burlison) introduced the
following bill; which was referred to the Committee on Foreign Affairs
_______________________________________________________________________
A BILL
To prohibit Federal funding to the Wuhan Institute of Virology and to
require a GAO study regarding Federal funds previously provided to such
institute or to entities affiliated with the Chinese Government.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Defund the Wuhan Institute of
Virology Act''.
SEC. 2. PROHIBITION ON FEDERAL FUNDING TO THE WUHAN INSTITUTE OF
VIROLOGY.
(a) In General.--No funds authorized or appropriated by Federal law
may be made available to the Wuhan Institute of Virology for any
purpose.
(b) GAO Study and Report.--Not later than 2 years after the date of
the enactment of this Act, the Comptroller General of the United States
shall conduct a study and submit a report to Congress regarding the
amount of Federal funds that were awarded or indirectly provided
(whether purposely or inadvertently) during the 15-year period
immediately preceding such date of enactment to--
(1) the Wuhan Institute of Virology, including affiliated
researchers;
(2) the People's Republic of China;
(3) the Chinese Communist Party; or
(4) any agency or instrumentality of the entities listed in
paragraphs (1) through (3).
<all>